Microsphere formulation has been highlighted as a promising dosage form in clinical practice due to its ability to significantly improve patient convenience and compliance. As a trustworthy partner in the field of pharmaceutical formulation, CD Formulation has newly introduced a range of raw materials for the production of microspheres and microneedles, which are highly expected to advance innovative drug delivery systems and non-invasive procedures.
Compared with conventional formulations, microspheres enable long-term and stable drug release in the body, making them a perfect choice for immunization, gene therapy and tumor chemotherapy.
“With the increasing demand for targeted drug delivery and minimally invasive procedures, there is a growing need for high-quality polymer microspheres and raw materials. Considering this, we decided to introduce such a new product line, with different material sizes, shapes, and compositions, to help researchers and manufacturers achieve the desired drug release profile and tissue penetration,” said the Marketing Director of CD Formulation.
Polymer Microspheres
The polymer microspheres range in diameter from 1 to 200 microns and can be loaded with different drugs or bioactive molecules depending on the application. The microspheres can be injected or implanted into the target tissue or organ, allowing the drug to be released locally with minimal systemic effects. Polymeric microspheres are widely used in the development of particulate drug delivery systems because of their high biocompatibility. The polymer microspheres offered by CD Formulation can be divided into three sub-categories, i.e., PCL microspheres, PLA microspheres, and PLGA microspheres.
Raw Materials
In addition to polymer microspheres, CD Formulation offers a wide range of raw materials, including inorganic materials, microneedle materials and polymers, for the manufacture of microspheres and microneedles. These materials are carefully selected and tested to meet the highest quality standards and ensure compatibility with polymer microspheres. To name just a few: Magnetic Iron Oxide Nanoparticle Solution (CAS 1317-61-9), Hydroxyapatite (CAS 1306-06-5), Calcium Carbonate (CAS 471-34-1), Poly(dimethylsiloxane) (CAS 107-51-7), Carboxymethylcellulose Sodium Salt (CAS 9004-32-4), Blue dextran (CAS 87915-38-6), 2-(Dimethylamino)pyridine (CAS 5683-33-0), Methacrylic anhydride (CAS 760-93-0), Polylactic acid (CAS 26100-51-6), Poly(D,L-lactide-co-glycolide) (50: 50), Poly(D,L-lactide), PLCL-PEG-PLCL, Poly[1,6-bis(p-carboxyphenoxy)hexane], and others.
Besides, CD Formulation offers other types of microspheres to customers worldwide, including CaCO3 microspheres and hollow silica microspheres (CAS 7631-86-9). Both are widely used as drug delivery systems.
Please visit https://msmn.formulationbio.com/products.html to learn more about CD Formulation’s 100+ raw materials for microsphere and microneedle manufacturing.
About CD Formulation
CD Formulation’s advanced polymer microspheres and raw materials are trusted by researchers and manufacturers around the world for their reliable performance, consistent quality, and versatility. With its commitment to innovation and customer satisfaction, CD Formulation will continue to lead the way in the development of next-generation drug delivery systems.
